BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 27378475)

  • 1. A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis.
    Anders HJ; Rovin B
    Kidney Int; 2016 Sep; 90(3):493-501. PubMed ID: 27378475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis.
    Yung S; Chan TM
    Clin Immunol; 2017 Dec; 185():40-50. PubMed ID: 27612436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Sm is associated with the early poor outcome of lupus nephritis.
    Ahn SS; Yoo BW; Song JJ; Park YB; Lee SK; Lee SW
    Int J Rheum Dis; 2016 Sep; 19(9):897-902. PubMed ID: 27126359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laboratory and morphologic parameters in patients with lupus nephritis].
    Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus nephritis: update on mechanisms of systemic autoimmunity and kidney immunopathology.
    Lorenz G; Desai J; Anders HJ
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):211-7. PubMed ID: 24662982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus nephritis: the evolving role of novel therapeutics.
    Rovin BH; Parikh SV
    Am J Kidney Dis; 2014 Apr; 63(4):677-90. PubMed ID: 24411715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.
    Clark MR; Trotter K; Chang A
    Semin Nephrol; 2015 Sep; 35(5):455-64. PubMed ID: 26573548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy.
    Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP
    Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of necrosis in lupus nephritis.
    Makino H; Hayashi Y; Yamasaki Y; Shikata K; Kashihara N; Kira S; Ota Z
    Intern Med; 1994 Aug; 33(8):461-5. PubMed ID: 7803911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Lupus Nephritis Pathogenesis: From Bench to Bedside.
    Obrișcă B; Sorohan B; Tuță L; Ismail G
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
    Fraenkel L; MacKenzie T; Joseph L; Kashgarian M; Hayslett JP; Esdaile JM
    J Rheumatol; 1994 Nov; 21(11):2052-7. PubMed ID: 7869309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice.
    Fenton K; Fismen S; Hedberg A; Seredkina N; Fenton C; Mortensen ES; Rekvig OP
    PLoS One; 2009 Dec; 4(12):e8474. PubMed ID: 20041189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis.
    Malvar A; Alberton V; Lococo B; Ferrari M; Delgado P; Nagaraja HN; Rovin BH
    Kidney Int; 2020 Jan; 97(1):156-162. PubMed ID: 31685314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathology of lupus nephritis.
    Anders HJ; Fogo AB
    Semin Immunopathol; 2014 Jul; 36(4):443-59. PubMed ID: 24402709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual association of anti-GBM diseases and lupus nephritis presenting as pulmonary renal syndrome.
    Yadla M; Krishnakishore C; Reddy S; Naveen PS; Sainaresh VV; Reddy MK; Sivakumar V
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):349-51. PubMed ID: 21422643
    [No Abstract]   [Full Text] [Related]  

  • 16. Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis?
    Giannico G; Fogo AB
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):138-45. PubMed ID: 22977215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of antinuclear antibody (ANA) immunofluorescent patterns and titers in systemic lupus erythematosus nephritis.
    Akbar S; Tello AI; Luvira U; Heinzerling R; Romanski R; Levin NW; Burnham TK
    Henry Ford Hosp Med J; 1988; 36(2):121-9. PubMed ID: 3068209
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffuse proliferative crescentic lupus nephritis with normal renal function.
    Gupta V; Sachdeva S; Khan AS; Haque SF
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):343-5. PubMed ID: 22382232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus nephritis.
    Agrawal N; Chiang LK; Rifkin IR
    Semin Nephrol; 2006 Mar; 26(2):95-104. PubMed ID: 16530602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.